LIVING Study Phase III
NCT02346487 | Kenya, Uganda
Lopinavir/ritonavir pellets with dual NRTIs implemenation study in infants and young children.
LOLIPOP Study Phase I/II
NCT03836833 | Uganda
Lopinavir/r/ Lamivudine/ Abacavir as an easy-to-use paediatric formulation.
NCT02348177 | South Africa | Completed
Pharmacokinetics of lopinavir/ritonavir superboosting in infants and young children co-infected with HIV and TB.
- Results presented at CROI 2017
- Results in The Lancet HIV (2019)
- DNDi project page
Last update: February 2019